Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Go back to Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results| (NASDAQ: PRAX) | Delayed: 353.32 +1.51 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $351.81 | 52 Week High | $ | |||
| Open | $342.25 | 52 Week Low | $ | |||
| Day High | $356.29 | P/E | N/A | |||
| Day Low | $339.50 | EPS | $ | |||
| Volume | 181,810 | |||||

